Sunday, October 17, 2021
News for Retirees


Courtroom Upholds Rejection of Pfizer Medicare Co-Pay Help

Share this…FacebookPinterestTwitterLinkedin A Pfizer Inc. proposal to cowl Medicare co-pay prices related to a coronary heart drug that prices $225,000…

By Staff , in Medicare , at October 2, 2021



A Pfizer Inc. proposal to cowl Medicare co-pay prices related to a coronary heart drug that prices $225,000 per yr would doubtless violate the Anti-Kickback Statute, a federal court docket dominated.

Pfizer was difficult the Division of Well being and Human Providers’ rejection of the co-pay help program in a September 2020 advisory opinion.

The Division of Justice has just lately been cracking down on drugmakers which have allegedly used charities and co-pay help applications to extend gross sales by eradicating price obstacles confronted by sufferers. Settlements ensuing from the enforcement drive have netted the federal government greater than $1 billion.

The statute prohibits funds meant …



Source link

Skip to content